I-Mab Biopharma
Executives
View the org chart displaying its 20 main executives
Most searched biographies at I-Mab Biopharma
- Raj Kannan, Chief Executive Officer and Director
- Chia-Hung Yang, Independent Director
- Rong Shao, Director
Popular executive movements at I-Mab Biopharma
- Lan Kang, Director, has left the company (posted on April 3 2024).
Create your alert
to follow the executive moves at I-Mab Biopharma.
Pharmaceuticals
I-Mab Biopharma has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by I-Mab Biopharma
- I-Mab | I-Mab Announces First Patient Dosed in Phase 1 Clinical Trial of Claudin 18.2 and 4-1BB Bispecific Antibody TJ-CD4B in Solid Tumors in China
- I-Mab | I-Mab to Present Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab at ESMO Congress 2022
- I-Mab | News Releases
- I-Mab | I-Mab to Host 2022 R&D Day
- I-Mab | I-Mab Receives Top Rankings in Five Categories by Institutional Investor
- I-Mab | I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210
- I-Mab | I-Mab Announces Completion of Patient Enrollment in Phase III Clinical Trial of Eftansomatropin alfa for Treatment of Pediatric Growth Hormone Deficiency
- I-Mab | I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
- I-Mab | News Releases
- I-Mab | I-Mab to Hold Investor Call to Report Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
- View more press releases Close
Social media about I-Mab Biopharma
- I-Mab Biopharma on Wikipedia, Google News & Yahoo Finance
- I-Mab Biopharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Raj Kannan 
Call I-Mab Biopharma at +86 216...
